Loading clinical trials...
Loading clinical trials...
A Multi-site, Open-Label, Parallel-Group Study To Evaluate Changes In Tobacco-Related Biomarkers of Exposure and Biomarkers of Potential Harm With Use of Heated Tobacco Products Compared to Combustible Cigarettes in Adult Smokers
Conditions
Interventions
Ploom HTP Menthol HTS; MX3 (681)
Ploom HTP Tobacco HTS; R8 (120)
+2 more
Locations
7
United States
Woodland Research Northwest
Rogers, Arkansas, United States
Dr. Vince Clinical Research, LLC
Overland Park, Kansas, United States
Alliance for Multispecialty Research, LLC
Lexington, Kentucky, United States
QPS Bio-Kinetic
Springfield, Missouri, United States
Celerion Lincoln
Lincoln, Nebraska, United States
Alliance for Multispecialty Research, LLC
Knoxville, Tennessee, United States
Start Date
October 2, 2023
Primary Completion Date
May 15, 2024
Completion Date
March 24, 2025
Last Updated
May 4, 2025
NCT07292883
NCT07466875
NCT06218056
NCT06372899
NCT06264154
NCT06295757
Lead Sponsor
Altria Client Services LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions